检索历史清除

首页> The oncologist> FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

导出原文传递

翻译打印收藏纠错

作者： Kazandjian, Dickran ^[1] ; Suzman, Daniel L. ; Blumenthal, Gideon ; Mushti, Sirisha ; He, Kun ; Libeg, Meredith ; Keegan, Patricia ; Pazdur, Richard

作者单位： US FDA, White Oak Campus,10903 New Hampshire Ave, Silver Spring, MD 20993 USA ^[1]

关键词 Nivolumab Non-small cell lung carcinoma PD-1 inhibitor Immunotherapy

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交